A61K 31/455
Nicotinic acids
Official title: Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
A61K31/455 (Nicotinic acids) appears on 1,250 US grants and 2,337 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,250
- Published applications
- 2,337
- Assignees
- 1,069
- Inventors
- 3,835
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 4 | 0 |
| 1978 | 7 | 0 |
| 1979 | 4 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 4 | 0 |
| 1986 | 3 | 0 |
| 1987 | 5 | 0 |
| 1988 | 16 | 0 |
| 1989 | 7 | 0 |
| 1990 | 3 | 0 |
| 1991 | 6 | 0 |
| 1992 | 5 | 0 |
| 1993 | 10 | 0 |
| 1994 | 9 | 0 |
| 1995 | 11 | 0 |
| 1996 | 6 | 0 |
| 1997 | 10 | 0 |
| 1998 | 14 | 0 |
| 1999 | 25 | 0 |
| 2000 | 37 | 0 |
| 2001 | 23 | 8 |
| 2002 | 26 | 32 |
| 2003 | 22 | 64 |
| 2004 | 27 | 57 |
| 2005 | 15 | 62 |
| 2006 | 19 | 89 |
| 2007 | 11 | 105 |
| 2008 | 17 | 73 |
| 2009 | 16 | 63 |
| 2010 | 24 | 69 |
| 2011 | 20 | 73 |
| 2012 | 43 | 78 |
| 2013 | 45 | 73 |
| 2014 | 42 | 89 |
| 2015 | 45 | 108 |
| 2016 | 55 | 140 |
| 2017 | 61 | 105 |
| 2018 | 67 | 102 |
| 2019 | 56 | 112 |
| 2020 | 73 | 97 |
| 2021 | 59 | 136 |
| 2022 | 64 | 145 |
| 2023 | 60 | 142 |
| 2024 | 63 | 124 |
| 2025 | 53 | 88 |
| 2026 | 41 | 103 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for improving bioavailability of NAD+ derivatives22 Sep 2026US 12,740,966 B2Hoboomlife Bio-Technology (Shenzhen) Co., Ltd.
- Treatment of urothelial and kidney cancers by use of endothelin B receptor antagonists8 Sep 2026US 12,728,122 B2ENB Therapeutics, Inc.
- Powdered food supplement for producing a beverage1 Sep 2026US 12,721,878 B2PM-International AG
- Nicotinic acid derivative A with anti-inflammation and anti-platelet aggregation activities, and use thereof11 Aug 2026US 12,702,664 B2Chongqing Academy of Chinese Materia Medica
- Antiviral supplement formulations11 Aug 2026US 12,702,677 B2Vymedic, LLC
- Nutritional compositions, supplements, and fortifiers8 Oct 2026US 2026/0306432 A1Societe des Produits Nestle S. A.
- Psilocybin compositions8 Oct 2026US 2026/0306474 A1Turtle Bear Holdings, LLC
- Liquid and solid compositions of imipridone derivatives8 Oct 2026US 2026/0306494 A1Assistance Publique-Hopitaux de Paris
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
- Beta-hydroxybutyrate for the dietary management of depression1 Oct 2026US 2026/0294854 A1Laureate Institute For Brain Research
Most cited
By later US patents
- Dosage form for high dose-high solubility active ingredients that provides for immediate release and modified release of the active ingredients174US 8,263,125 B2Torrent Pharmaceuticals Limited · 2012
- Sterile bioerodible occular implant device with a retinoid for improved biocompatability170US 6,074,661 AAllergan Sales, Inc. · 2000
- Pharmaceutical composition containing acid addition salt of basic drug163US 6,255,502 B1Farmarc Nederland BV · 2001
- Controlled release tablet containing water soluble medicament150US 5,126,145 A1992
- Implant device with a retinoid for improved biocompatibility136US 6,537,568 B2Allergan, Inc. · 2003